Cliniphar Ltd.

¥1,450As of Sun 8 Nov 2026, 12:00 UTC
TSE:432AHealthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 14.25%
Medical (Pharmaceuticals)
Beta (5Y) —
PE TTM 9.006
TSR TTM —
Mkt cap ¥1.450B
ROIC 12.59%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥1,619
11.68%
196.65%
Hold 3|8|1|5|0
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
26.58
26.49
28.29
29.13
20.35%
24.14%
19.51%
20.99%
Revenue¥M
67.16
67.61
66.46
70.42
6.67%
4.44%
2.51%
11.13%
Peers (US$9.206M)
Cap (US$)
PE
19.91M
17.69x
19.24M
54.62x
Capital
TTM
5Y
10Y
Leveragex
0.603
0.217
0.248
EBIT/Intx
0.951
0.840
0.635
Own earn%
45.10
(166.22)
(159.15)
Sh yield%
35.27
40.48
40.61
Owners
Insiders/Inst%
10.37
45.25
Short interest%
3.20
SBC / revenue%
4.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
0–13
$1 testx
−0.1
Incr. ROIC%
9